5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with nitroarginine in 1 studies
| Studies (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Trials (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Recent Studies (post-2010) (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Studies (nitroarginine) | Trials (nitroarginine) | Recent Studies (post-2010) (nitroarginine) |
|---|---|---|---|---|---|
| 73 | 0 | 8 | 3,935 | 11 | 175 |
| Protein | Taxonomy | 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide (IC50) | nitroarginine (IC50) |
|---|---|---|---|
| Nitric oxide synthase, endothelial | Bos taurus (cattle) | 1.2 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 0.38 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 1.265 | |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 4.12 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.5 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 6.2 | |
| Nitric oxide synthase, brain | Mus musculus (house mouse) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franco-Cereceda, A; Holm, P; Liska, J | 1 |
1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and nitroarginine
| Article | Year |
|---|---|
The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.
Topics: Animals; Antihypertensive Agents; Dansyl Compounds; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Nitric Oxide Synthase; Nitroarginine; Pulmonary Artery; Swine | 1998 |